Ad
related to: placebo
Search results
Increase alpha brainwave levels to create a state of relaxed alertness, reducing anxiety and stress
Nutraingredients.com· 30 minutes agoThe effects of stress in life today cannot be overstated. The American Psychological Association in their 2022 Stress in America report stated that: “The US population has experienced an intense ...
Interim results of IGNAZ trial sheds positive light on felzartamab for IgAN
Clinical Trials Arena via Yahoo Finance· 4 hours agoGlobalData believes that this study could be of high clinical value to nephrologists who are seeking...
Innovent’s psoriasis treatment picankibart meets all endpoints in Phase III trial
Clinical Trials Arena via Yahoo Finance· 1 day agoThe multicentre, double-blind, placebo-controlled study enrolled 500 subjects, who were randomised...
Novartis (NVS) Presents Positive Data on Renal Drugs at ERA
Zacks via Yahoo Finance· 2 days agoAPPEAR-C3G is a phase III multicenter, randomized, double-blind, parallel-group, placebo-controlled...
NS Pharma reports data from Phase III Duchenne treatment trial
Clinical Trials Arena via Yahoo Finance· 1 day agoThe randomised, placebo-controlled study enrolled 77 male patients with DMD who were able to walk....
J&J antidepressant eases symptoms, improves sleep in key trial
BioPharma Dive via Yahoo Finance· 7 hours agoJ&J said its drug was “safe and well-tolerated” in the study, noting that rates of common side...
Insmed shares target raised by H.C. Wainwright on positive trial data By Investing.com
Investing.com· 8 hours agoThe ASPEN trial results showed a reduction in annualized rates of pulmonary exacerbations (PEs) for...
Merck’s KEYTRUDA shows survival benefits in Phase III TNBC trial
Clinical Trials Arena via Yahoo Finance· 10 hours agoThe double-blind randomised study involved a total of 1,174 patients. Participants were assigned in...
HI-Bio Announces Positive Results from Phase 2 Study of Felzartamab for Late Antibody-Mediated...
WLNS Lansing· 4 days ago82% (n=9/11) of patients on felzartamab experienced resolution of antibody-mediated rejection per Banff criteria on biopsy at 24 weeks versus 20% (n=2/10) who received placebo
GLP-2 Analog Reduces Need for Parenteral Support in Patients With Rare GI Condition
MedPage Today· 7 days agoBetter outcomes in short bowel syndrome and intestinal failure with apraglutide vs placebo
